Twelve innovative therapies become available from May
…assessed by the NEAK, therefore it is often labelled too slow and bureaucratic. In its answer the NEAK also acknowledged that the revision of the reimbursement system is necessary, in order to make sure only those products get reimbursement that bring proven health benefit for patients.
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)